Articles

Natural history of Waldenström macroglobulinemia following acquired resistance to ibrutinib monotherapy

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA; Boston University School of Medicine
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston MA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston MA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston MA
Department of Medicine, Harvard Medical School, Boston MA, USA; Division of Medical Oncology, Massachusetts General Hospital, Boston MA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston MA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston MA
Haematologica Early view Jun 24, 2021 https://doi.org/10.3324/haematol.2021.279112